Cancer Research Technology
Log in Register
Menu

Anti-Integrin a4 [7.2]

Invented at Queen Mary University of London

Info

Catalogue Number 151218
Applications FACS IHC IP WB
Antigen/Gene or Protein Targets Integrin alpha 4 (VLA-4; CD49d)
Reactivity Human
Relevance Monoclonal antibody directed at integrin a4/b1, which forms part of VLA-4.

Background and Research Application
Integrins are heterodimeric cell surface receptors composed of alpha and beta subunits, which mediate cell-cell and cell-extracellular matrix attachments. Aberrant integrin expression has been found in many epithelial tumours. Changes in integrin expression have been shown to be important for the growth and early metastatic capacity of melanoma cells.
Integrin alpha 4 combines with beta-1 integrin to form the Integrin alpha4/ beta1 lymphocyte homing receptor: Very Late Antigen 4 (VLA-4). VLA-4 plays a major role in lymphocyte extravasation, via binding to VCAM on endothelial cells. VLA-4 also binds fibronectin and mediates homotypic and heterotypic cell-cell adhesion between lymphocytes. Integrin alpha 4/ beta 1 also binds the mucosal addressin cell adhesion molecule (MAdCAM-1).
Host Mouse
Immunogen Human melanoma line DX3
Immunogen UniProt ID P13612
Positive Control U937 human histiocytic lymphoma cell line
Subclass IgG1
Notes Production Details
Purified using multi-step affinity chromatography with protein A.

Storage Conditions
Store at -20 degrees frozen. Avoid repeated freeze/thaw cycles.

Points of Interest
Recommended for histology on unfixed tissue culture cells.

Concentration
1mg/ml as standard
Research Area Adhesion, Cardiovascular, Cell Signaling & Signal Transduction, Immunology, Stem Cell Biology

References

There are 4 reference entries for this reagent.

View All References

References: 4 entries

McDowall et al. 2003. J Clin Invest. 111(1):51-60. PMID: 12511588.

A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins.

Europe PMC ID: 12511588

Leitinger et al. 2002. J Cell Sci. 115(Pt 5):963-72. PMID: 11870215.

The involvement of lipid rafts in the regulation of integrin function.

Europe PMC ID: 11870215


Add a reference

References: 4 entries

McDowall et al. 2003. J Clin Invest. 111(1):51-60. PMID: 12511588.

A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins.

Leitinger et al. 2002. J Cell Sci. 115(Pt 5):963-72. PMID: 11870215.

The involvement of lipid rafts in the regulation of integrin function.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor